CPAF 2023/24 screening questionnaire to be available from 3rd July for pharmacy contractors

Date:

Share post:

The Community Pharmacy England has asked its members to complete the 2023/24 Community Pharmacy Assurance Framework (CPAF) screening questionnaire which will be available from Monday (3 July) until midnight on Sunday (30 July).

“As a result of NHS regulations introduced at the end of 2020, completion of CPAF is now a requirement of the Terms of Service. Therefore, contractors must complete the screening questionnaire and, if required, the full CPAF questionnaire,” said Community Pharmacy England. 

The short screening questionnaire consists of 10 questions. Contractors who use the NHS Business Services Authority (NHSBSA) Manage Your Service (MYS) portal will be required to complete the questionnaire on the portal. Contractors who are not yet signed up to MYS will be able to complete the questionnaire online.

The questions will be published on the NHSBSA website ahead of the 3rd July 2023 go-live date to give contractors advance notice of these.

Once the screening questionnaires have been completed, NHS England will then select a small number of pharmacies for a monitoring visit and/or to complete the full CPAF questionnaire.

Community Pharmacy England has published a short Briefing on the screening process.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...